Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study-Reference-Cited by-同舟云学术

Immune checkpoint inhibitors in patients aged 80 or older with advanced non-small cell lung cancer or melanoma: a real-life multicentre study

Published:2022-10-14 Issue:11 Volume:61 Page:1339-1346
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Benguerfi Soraya¹,Lesimple Thierry²,Houot Roch³,Ricordel Charles⁴⁵,Legoupil Delphine⁶,Alleaume Corinne⁷,Lamy Régine⁸,Deniel Lagadec Delphine⁶⁹,Corre Romain¹⁰

Affiliation:

1. CHU Rennes, Hôpital Pontchaillou, Université de Rennes 1, Rennes, France

2. Department of Medical Oncology, Centre Eugène Marquis, Rennes, France

3. Department of Hematology, CHU de Rennes, INSERM U1236, University of Rennes, Rennes, France

4. Department of Respiratory Medicine, Pontchaillou Hospital, Rennes 1 University, Rennes, France

5. INSERM, OSS (Oncogenesis Stress Signaling), UMR_S 1242, CLCC Eugene Marquis, Université de Rennes 1, Rennes, France

6. Department of Dermatology, Centre Hospitalier Universitaire Brest Morvan, Brest, France

7. Department of Medical Oncology, CH Saint-Brieuc, Saint-Brieuc, France

8. CH Bretagne Sud, Lorient, France

9. Unité de Coordination en Oncogériatrie de Bretagne, Centre Hospitalier Universitaire de Brest, Brest, France

10. Department of Medical Oncology, CH de Cornouaille, Quimper, France

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2022.2132114

Reference34 articles.

1. Nivolumab in Previously Untreated Melanoma withoutBRAFMutation

2. Pembrolizumab versus Ipilimumab in Advanced Melanoma

3. Nivolumab plus Ipilimumab in Advanced Melanoma

4. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

5. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database;Journal of Geriatric Oncology;2024-09

2. Age-associated changes in the gut microbiome impact efficacy of tumor immunomodulatory treatments;Experimental Gerontology;2023-10